Acrivon Therapeutics, Inc. (ACRV) stock
ACRVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.56+0.13 (+9.09%)
Close on Nov 18, 2026Market cap $66.85MP/E –Yield –
Acrivon Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Acrivon Therapeutics's market cap was $67.27M on Nov 11, 2026, against $74.46M a year earlier. Over the last 4 years it ranged from $20.67M to $445.42M, with a median of $89.52M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $67.27M | -11.5% |
| 2025 | Dec 31, 2025 | $76.03M | -59.4% |
| 2024 | Dec 31, 2024 | $187.41M | +72.3% |
| 2023 | Dec 29, 2023 | $108.75M | +426.0% |
| 2022 | Dec 30, 2022 | $20.67M | – |
See a number that looks wrong?